{
    "root": "35cfa9cc-5292-a34b-e063-6394a90ab1ff",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Diazepam",
    "value": "20250523",
    "ingredients": [
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "DIAZEPAM",
            "code": "Q3JTX2Q7TU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_49575"
        }
    ],
    "indications": {
        "text": "diazepam tablets indicated management anxiety disorders short-term relief symptoms anxiety . anxiety tension associated stress everyday life usually require treatment anxiolytic . acute alcohol withdrawal , diazepam tablets may useful symptomatic relief acute agitation , tremor , impending acute delirium tremens hallucinosis . diazepam useful adjunct relief skeletal muscle spasm due reflex spasm local pathology ( inflammation muscles joints , secondary trauma ) , spasticity caused upper motor neuron disorders ( cerebral palsy paraplegia ) , athetosis , stiff-man syndrome . oral diazepam may used adjunctively convulsive disorders , although proved useful sole therapy . effectiveness diazepam long-term , , 4 months , assessed systematic . physician periodically reassess usefulness individual patient .",
        "doid_entities": [
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            },
            {
                "text": "delirium tremens (DOID:8639)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8639"
            },
            {
                "text": "cerebral palsy (DOID:1969)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1969"
            },
            {
                "text": "paraplegia (DOID:607)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_607"
            },
            {
                "text": "stiff-man syndrome (DOID:13366)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13366"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "stiff-man syndrome",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_353298"
            },
            {
                "disease": "acute delirium tremens",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_90062"
            }
        ]
    },
    "contraindications": {
        "text": "individualized maximum beneficial effect . usual daily dosages given meet needs patients , may require higher doses . cases , increased cautiously avoid effects . adults : usual daily dose : management anxiety disorders relief symptoms anxiety . depending upon severity symptoms \u2013 2 mg 10 mg , 2 4 times daily symptomatic relief acute alcohol withdrawal . 10 mg , 3 4 times first 24 hours , reducing 5 mg , 3 4 times daily needed . adjunctively relief skeletal muscle spasm . 2 mg 10 mg , 3 4 times daily adjunctively convulsive disorders . 2 mg 10 mg , 2 4 times daily geriatric patients , presence debilitating disease . 2 mg 2.5 mg , 1 2 times daily initially ; increase gradually needed tolerated . pediatric patients : varied responses cns-acting drugs , initiate therapy lowest dose increase required . pediatric patients 6 months . 1 mg 2.5 mg , 3 4 times daily initially ; increase gradually needed tolerated .",
        "doid_entities": [
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "diazepam tablets usp , 10 mg available light blue , round , flat face , beveled edge tablets , debossed \u201c 3927 \u201d bisected one side \u201c teva \u201d side , containing 10 mg diazepam , usp . ndc : 70518-0014-00 packaging : 30 1 blister pack store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp , child-resistant closure ( required ) . keep medications reach children . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "diazepam tablets contraindicated patients known hypersensitivity diazepam , lack sufficient experience , pediatric patients 6 months age . diazepam tablets also contraindicated patients myasthenia gravis , severe respiratory insufficiency , severe hepatic insufficiency , sleep apnea syndrome . may used patients open-angle glaucoma receiving appropriate therapy , contraindicated acute narrow-angle glaucoma .",
    "indications_original": "Diazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.\n                  In acute alcohol withdrawal, diazepam tablets may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis.\n                  Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia), athetosis, and stiff-man syndrome.\n                  Oral diazepam may be used adjunctively in convulsive disorders, although it has not proved useful as the sole therapy.\n                  The effectiveness of diazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.",
    "contraindications_original": "Dosage should be individualized for maximum beneficial effect. While the usual daily dosages given below will meet the needs of most patients, there will be some who may require higher doses. In such cases, dosage should be increased cautiously to avoid adverse effects.\n                  \n                     \n                     \n                     \n                        \n                           \u00a0\n    \n     \n                                 ADULTS:\n                              \n                           \n                           \u00a0\n    \n     \n                                 USUAL DAILY DOSE:\n                              \n                           \n                        \n                        \n                           \u00a0\n                           \u00a0\n                        \n                        \n                           \u00a0\n    \n     \n                                 Management of Anxiety Disorders and Relief of Symptoms of Anxiety.\n                              \n                           \n                           \u00a0\n    \n     Depending upon severity of symptoms \u2013 2 mg to 10 mg, 2 to 4 times daily\n                           \n                        \n                        \n                           \u00a0\n                           \u00a0\n                        \n                        \n                           \u00a0\n    \n     \n                                 Symptomatic Relief in Acute Alcohol Withdrawal.\n                              \n                           \n                           \u00a0\n    \n     10 mg, 3 or 4 times during the first 24 hours, reducing to 5 mg, 3 or 4 times daily as needed.\n                           \n                        \n                        \n                           \u00a0\n                           \u00a0\n                        \n                        \n                           \u00a0\n    \n     \n                                 Adjunctively for Relief of Skeletal Muscle Spasm.\n                              \n                           \n                           \u00a0\n    \n     2 mg to 10 mg, 3 or 4 times daily\n                           \n                        \n                        \n                           \u00a0\n                           \u00a0\n                        \n                        \n                           \u00a0\n    \n     \n                                 Adjunctively in Convulsive Disorders.\n                              \n                           \n                           \u00a0\n    \n     2 mg to 10 mg, 2 to 4 times daily\n                           \n                        \n                        \n                           \u00a0\n                           \u00a0\n                        \n                        \n                           \u00a0\n    \n     \n                                 Geriatric Patients, or in the presence of debilitating disease.\n                              \n                           \n                           \u00a0\n    \n     2 mg to 2.5 mg, 1 or 2 times daily initially; increase gradually as needed and tolerated.\n                           \n                        \n                        \n                           \u00a0\n                           \u00a0\n                        \n                        \n                           \u00a0\n    \n     \n                                 PEDIATRIC PATIENTS:\n                              \n                           \n                           \u00a0\n                        \n                        \n                           \u00a0\n                           \u00a0\n                        \n                        \n                           \u00a0\n    \n     Because of varied responses to CNS-acting drugs, initiate therapy with lowest dose and increase as required. Not for use in pediatric patients under 6 months.\n                           \n                           \u00a0\n    \n     1 mg to 2.5 mg, 3 or 4 times daily initially; increase gradually as needed and tolerated.",
    "warningsAndPrecautions_original": "Diazepam Tablets USP, 10 mg are available as light blue, round, flat face, beveled edge tablets, debossed \u201c3927\u201d and bisected on one side and \u201cTEVA\u201d on the other side, containing 10 mg of diazepam, USP.\n                  NDC: 70518-0014-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [See USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  Keep this and all medications out of the reach of children.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Diazepam tablets are contraindicated in patients with a known hypersensitivity to diazepam and, because of lack of sufficient clinical experience, in pediatric patients under 6 months of age. Diazepam tablets are also contraindicated in patients with myasthenia gravis, severe respiratory insufficiency, severe hepatic insufficiency, and sleep apnea syndrome. They may be used in patients with open-angle glaucoma who are receiving appropriate therapy, but are contraindicated in acute narrow-angle glaucoma.",
    "drug": [
        {
            "name": "Diazepam",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_49575"
        }
    ]
}